Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni
- PMID: 11897756
- DOI: 10.1161/hy0302.104669
Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni
Abstract
Previous studies have shown that in the population, only a minority of treated hypertensive patients achieve blood pressure (BP) control. Whether and to what extent this inadequate control has reflection on hypertension-related organ damage has never been systematically examined. In 2051 subjects belonging to the PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) Study population, we measured office, home, and 24-hour ambulatory BP values, together with echocardiographic left ventricular mass and wall thickness. Based on the fraction on antihypertensive treatment and on measurements of increased or normal office, home, or 24-hour ambulatory BP values, subjects were classified as normotensives, untreated hypertensives, treated hypertensives with inadequate BP control, and treated hypertensives with effective BP control. Compared with values in the normotensive group, left ventricular mass index, left ventricular wall thickness, and prevalence of left ventricular hypertrophy were markedly increased not only in untreated hypertensive patients but also in treated hypertensives with inadequate BP control. Echocardiographic abnormalities were less in treated hypertensives with BP control than in patients with inadequate BP control, but values were still clearly greater than in normotensive subjects. This was the case regardless whether BP control was assessed by office, home, and/or ambulatory values. Our data provide evidence that in the hypertensive fraction of the population, cardiac structural alterations can be frequently found in both the presence and absence of antihypertensive treatment. They also imply that even effective treatment of hypertension does not allow complete reversal of the cardiac organ damage characterizing high BP states.
Similar articles
-
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study).Circulation. 2001 Sep 18;104(12):1385-92. doi: 10.1161/hc3701.096100. Circulation. 2001. PMID: 11560854
-
Nighttime blood pressure and new-onset left ventricular hypertrophy: findings from the Pamela population.Hypertension. 2013 Jul;62(1):78-84. doi: 10.1161/HYPERTENSIONAHA.111.00682. Epub 2013 May 20. Hypertension. 2013. PMID: 23690347
-
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.J Hypertens. 2016 Sep;34(9):1823-30. doi: 10.1097/HJH.0000000000001005. J Hypertens. 2016. PMID: 27348518
-
Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts.Curr Hypertens Rep. 2018 Jul 26;20(10):82. doi: 10.1007/s11906-018-0885-8. Curr Hypertens Rep. 2018. PMID: 30051144 Review.
-
Uric Acid, Hypertensive Phenotypes, and Organ Damage: Data from the Pamela Study.Curr Hypertens Rep. 2022 Feb;24(2):29-35. doi: 10.1007/s11906-022-01174-9. Epub 2022 Jan 25. Curr Hypertens Rep. 2022. PMID: 35076878 Free PMC article. Review.
Cited by
-
Mid- to Late-Life Time-Averaged Cumulative Blood Pressure and Late-Life Cardiac Structure, Function, and Heart Failure.Hypertension. 2020 Sep;76(3):808-818. doi: 10.1161/HYPERTENSIONAHA.120.14833. Epub 2020 Jun 15. Hypertension. 2020. PMID: 32536273 Free PMC article.
-
Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.Hypertension. 2007 Jun;49(6):1196-201. doi: 10.1161/HYPERTENSIONAHA.106.075085. Epub 2007 Apr 23. Hypertension. 2007. PMID: 17452509 Free PMC article. Review. No abstract available.
-
Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic.Malays Fam Physician. 2012 Aug 31;7(2-3):2-9. eCollection 2012. Malays Fam Physician. 2012. PMID: 25606250 Free PMC article.
-
Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy.Curr Hypertens Rep. 2020 Feb 3;22(2):11. doi: 10.1007/s11906-020-1017-9. Curr Hypertens Rep. 2020. PMID: 32016791 Review.
-
Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease.Med Sci Monit. 2013 Oct 9;19:838-45. doi: 10.12659/MSM.889586. Med Sci Monit. 2013. PMID: 24107785 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical